Cargando…

Stroke in MELAS is a Vasogenic Edema and not Ischemic

Detalles Bibliográficos
Autores principales:	Finsterer, Josef, Zarrouk-Mahjoub, Sinda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Iranian Neuroscience Society 2020
Materias:	Commentary Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502183/ https://www.ncbi.nlm.nih.gov/pubmed/32963730 http://dx.doi.org/10.32598/bcn.11.2.1271.1

Ejemplares similares

Arrhythmias in MELAS syndrome
por: Finsterer, Josef, et al.
Publicado: (2016)

Phenotypic heterogeneity of MELAS()()
por: Finsterer, Josef, et al.
Publicado: (2016)

MELAS can be psychiatric and neurological
por: Finsterer, Josef, et al.
Publicado: (2018)

MELAS syndrome due to the m.3291T > C mutation
por: Finsterer, Josef, et al.
Publicado: (2016)

Gastrointestinal Involvement in m.3243A>G-associated MELAS
por: Finsterer, Josef, et al.
Publicado: (2017)

Low blood heteroplasmy-rate may cause late-onset MELAS()()()
por: Finsterer, Josef, et al.
Publicado: (2017)

Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, and Stroke-like Episodes (MELAS) due to a m.10158T>C ND3 Mutation with a Normal Muscle Biopsy
por: Finsterer, Josef, et al.
Publicado: (2017)

Onset of MELAS due to the m.3243A > G mutation is early if the large phenotypic variability is considered()()
por: Finsterer, Josef, et al.
Publicado: (2016)

Is chronic fatigue syndrome truly associated with haplogroups or mtDNA single nucleotide polymorphisms?
por: Finsterer, Josef, et al.
Publicado: (2016)

A beneficial effect of l-arginine for stroke-like episodes is currently unsupported
por: Finsterer, Josef, et al.
Publicado: (2018)

Why does Leigh syndrome respond to immunotherapy?
por: Finsterer, Josef, et al.
Publicado: (2016)

Sinus venous thrombosis as a complication of COVID-19-associated hypercoagulability
por: Zarrouk, Sinda, et al.
Publicado: (2021)

Ischemic and Metabolic Stroke Can Co-occur in m.3243A>G Carriers: A Case Report
por: Finsterer, Josef, et al.
Publicado: (2022)

Stroke‐like lesions should not be mixed up with ischemic stroke in MELAS with cardioembolic risk
por: Finsterer, Josef
Publicado: (2023)

Involvement of the Microglial Aryl Hydrocarbon Receptor in Neuroinflammation and Vasogenic Edema after Ischemic Stroke
por: Tanaka, Miki, et al.
Publicado: (2021)

Comment on “A Rare Case of Renal Infarct due to Noncompaction Cardiomyopathy: A Case Report and Literature Review”
por: Finsterer, Josef, et al.
Publicado: (2016)

Non-compaction is not a simple genetic disorder
por: Finsterer, Josef, et al.
Publicado: (2014)

Phenotypic Heterogeneity of the m.14459G>A Mutation
por: Finsterer, Josef, et al.
Publicado: (2017)

Mitochondrial cardioencephalopathy due to a COQ4 mutation
por: Finsterer, Josef, et al.
Publicado: (2017)

Phenotypic heterogeneity of a compound heterozygous SUCLA2 mutation()()()
por: Finsterer, Josef, et al.
Publicado: (2016)

Pathogenicity of the Homoplasmic m.8701A>G Variant Requires Confirmation
por: Finsterer, Josef, et al.
Publicado: (2016)

Thiamin-Responsive PDH Deficiency due to a PDHA1 Variant
por: Finsterer, Josef, et al.
Publicado: (2018)

Heteroplasmy of the m.3243A>G Mutation May Influence Phenotypic Heterogeneity
por: Finsterer, Josef, et al.
Publicado: (2017)

Mitochondrial vasculopathy due to the m.3243A > G mutation is not restricted to the carotid artery
por: Finsterer, Josef, et al.
Publicado: (2016)

Mitochondrial myopathy, dysmorphism, exercise-induced vomiting and tachycardia the mutation m.4831G > A()
por: Finsterer, Josef, et al.
Publicado: (2017)

Mitochondrial multiorgan disorder syndrome (MIMODS) due to a compound heterozygous mutation in the ACAD9 gene()
por: Finsterer, Josef, et al.
Publicado: (2017)

Unusual recovery of respiratory chain complex-III deficiency upon G-tube feeding and a cocktail
por: Finsterer, Josef, et al.
Publicado: (2016)

Apply the Hirano or Japanese criteria when diagnosing MELAS
por: Finsterer, Josef, et al.
Publicado: (2022)

Assessment of the phenotype genotype variability and correlation in m.3243A > G mutation carriers requires prospective studies
por: Finsterer, Josef, et al.
Publicado: (2016)

Fibroblast growth-factor-21 is currently a weak biomarker for identifying mitochondrial and non-mitochondrial inborn errors of metabolism
por: Finsterer, Josef, et al.
Publicado: (2017)

Acquired non-compaction in integrin-myopathy
por: Finsterer, Josef, et al.
Publicado: (2013)

Impaired Hearing in Mitochondrial Disorders
por: Finsterer, Josef, et al.
Publicado: (2015)

Detection of the mutation may guide treatment of heart and muscle in Duchenne muscular dystrophy
por: Finsterer, Josef, et al.
Publicado: (2016)

Double trouble progressive external ophthalmoplegia and Huntington's disease()
por: Finsterer, Josef, et al.
Publicado: (2016)

Transient symmetric T2-hyperintensities of basal ganglia and brainstem not only point to Leigh syndrome
por: Finsterer, Josef, et al.
Publicado: (2016)

Nephrocalcinosis and retinal dystrophy, rare manifestations of MPV17-related mitochondrial depletion syndrome?()
por: Finsterer, Josef, et al.
Publicado: (2016)

Diagnosing Kearns-Sayre Syndrome Requires Genetic Confirmation
por: Finsterer, Josef, et al.
Publicado: (2016)

Specification of the Myopathy Type may Influence the Management of Noncompaction
por: Finsterer, Josef, et al.
Publicado: (2016)

Leber’s hereditary optic neuropathy is multiorgan not mono-organ
por: Finsterer, Josef, et al.
Publicado: (2016)

Diagnosis of Kearns-Sayre Syndrome Requires Comprehensive Work-up
por: Finsterer, Josef, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_gjkgqu2hhbte6eargo6fkcqqv3